163 related articles for article (PubMed ID: 33906875)
21. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
[TBL] [Abstract][Full Text] [Related]
22. Gene-Specific Variation in Colorectal Cancer Surveillance Strategies for Lynch Syndrome.
Kastrinos F; Ingram MA; Silver ER; Oh A; Laszkowska M; Rustgi AK; Hur C
Gastroenterology; 2021 Aug; 161(2):453-462.e15. PubMed ID: 33839100
[TBL] [Abstract][Full Text] [Related]
23. Milestones of Lynch syndrome: 1895-2015.
Lynch HT; Snyder CL; Shaw TG; Heinen CD; Hitchins MP
Nat Rev Cancer; 2015 Mar; 15(3):181-94. PubMed ID: 25673086
[TBL] [Abstract][Full Text] [Related]
24. Cancer risk in Lynch Syndrome.
Barrow E; Hill J; Evans DG
Fam Cancer; 2013 Jun; 12(2):229-40. PubMed ID: 23604856
[TBL] [Abstract][Full Text] [Related]
25. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
Reardon DA; Brandes AA; Omuro A; Mulholland P; Lim M; Wick A; Baehring J; Ahluwalia MS; Roth P; Bähr O; Phuphanich S; Sepulveda JM; De Souza P; Sahebjam S; Carleton M; Tatsuoka K; Taitt C; Zwirtes R; Sampson J; Weller M
JAMA Oncol; 2020 Jul; 6(7):1003-1010. PubMed ID: 32437507
[TBL] [Abstract][Full Text] [Related]
26. [A Case of Ascending Colon Cancer with Lynch Syndrome Who Underwent XELOX Adjuvant Chemotherapy].
Takase K; Murata K; Kagawa Y; Nose Y; Kawai K; Sakamoto T; Naito A; Murakami K; Katsura Y; Omura Y; Takeno A; Nakatsuka S; Takeda Y; Kato T; Tamura S
Gan To Kagaku Ryoho; 2018 Jan; 45(1):172-174. PubMed ID: 29362345
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls.
Adeleke S; Haslam A; Choy A; Diaz-Cano S; Galante JR; Mikropoulos C; Boussios S
Per Med; 2022 Jul; 19(4):277-286. PubMed ID: 35708161
[TBL] [Abstract][Full Text] [Related]
28. Lynch syndrome and related familial colorectal cancers.
Abdel-Rahman WM; Peltomäki P
Crit Rev Oncog; 2008; 14(1):1-22; discussion 23-31. PubMed ID: 19105568
[TBL] [Abstract][Full Text] [Related]
29. Cervical neuroendocrine tumor in a young female with Lynch Syndrome.
Yousef I; Siyam F; Layfield L; Freter C; Sowers JR
Neuro Endocrinol Lett; 2014; 35(2):89-94. PubMed ID: 24878972
[TBL] [Abstract][Full Text] [Related]
30. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
31. Understanding Lynch syndrome: implications for nursing.
Bannon E; Coleman EA
Clin J Oncol Nurs; 2007 Jun; 11(3):423-7. PubMed ID: 17623626
[TBL] [Abstract][Full Text] [Related]
32. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
Kravochuck SE; Church JM
ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
[TBL] [Abstract][Full Text] [Related]
33. Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma.
Lonati C; Moschini M; Simeone C; Spiess PE; Necchi A
Curr Opin Urol; 2022 Jan; 32(1):40-47. PubMed ID: 34608026
[TBL] [Abstract][Full Text] [Related]
34. Lynch Syndrome: Genomics Update and Imaging Review.
Cox VL; Saeed Bamashmos AA; Foo WC; Gupta S; Yedururi S; Garg N; Kang HC
Radiographics; 2018; 38(2):483-499. PubMed ID: 29528821
[TBL] [Abstract][Full Text] [Related]
35. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
36. Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome.
Pavelka Z; Zitterbart K; Nosková H; Bajčiová V; Slabý O; Štěrba J
Klin Onkol; 2019; 32(1):70-74. PubMed ID: 30764633
[TBL] [Abstract][Full Text] [Related]
37. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.
Lynch HT; Lanspa S; Shaw T; Casey MJ; Rendell M; Stacey M; Townley T; Snyder C; Hitchins M; Bailey-Wilson J
Fam Cancer; 2018 Jul; 17(3):403-414. PubMed ID: 29071502
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
[TBL] [Abstract][Full Text] [Related]
40. Lynch syndrome and sextuple primary malignancies.
Danys D; Stratilatovas E; Cereska V; Poskus T
Acta Chir Belg; 2018 Oct; 118(5):326-330. PubMed ID: 28938854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
